.jpg)
A Manx company has become the lead investor in a biotech company which is hoping to produce eat-yourself-thin foods.
Amphion Innovations has agreed a deal with American firm WellGen which has now received around £5 million in financing.
WellGen says the cash will be used to develop its line of nutraceuticals products, including an anti-obesity ingredient for use in functional foods.
It now plans to launch a human study of the ingredient’s effectiveness.
Investigation underway after customers report milk carton difficulties
Creamery apologies for cap issue
The Efficiency Trap: Why AI isn't saving us time
We were promised a 15-hour work week - so why does it feel like we're working more?
Understanding future technology trends 'essential' for election candidates
Event organisers highlight key opportunities and challenges for the Island
Bill will modernise employment and economic activity in the gambling sector
House of Keys agreed amendments made to document by the Legislative Council
